Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Journal of Occupational and Environmental Medicine|January 25, 2020
Non-Invasive and Minimally Invasive Management of Low Back DisordersKurt T Hegmann, Russell Travis, Gunnar B J Andersson, et al.
Vaccine|February 2, 2024
Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort studyPatrick Rivers, Cynthia Porter, Lindsay B LeClair, et al.
Open Forum Infectious Diseases|September 4, 2023
Humoral Immune Response to Messenger RNA Coronavirus Disease 2019 Vaccination Among Children Aged 5-11 Years in a Multisite Prospective Cohort Study, September 2021-September 2022Zoe L Lyski, Cynthia Porter, Jennifer L Uhrlaub, et al.
Open Forum Infectious Diseases|October 17, 2024
Relative Effectiveness and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Versus Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18-64 Years: Results and Experience From a Randomized, Double-Blind TrialLauren Grant, Jennifer A Whitaker, Sarang K Yoon, et al.
Plos One|December 31, 2024
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominanceJames Hollister, Cynthia Porter, Ryan Sprissler, et al.
Environmental Research|October 10, 2023
Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodiesJames Hollister, Alberto J Caban-Martinez, Katherine D Ellingson, et al.
JAMA Network Open|February 24, 2025
COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 YearsAnna R Yousaf, Josephine Mak, Lisa Gwynn, et al.
The Journal of Infectious Diseases|November 12, 2024
Association of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination and Reductions in Post COVID Conditions Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in a US Prospective Cohort of Essential WorkersJosephine Mak, Sana Khan, Amadea Britton, et al.
Diseases (Basel, Switzerland)|August 28, 2024
Evaluating Immunologic and Illness Outcomes of SARS-CoV-2 Infection in Vaccinated and Unvaccinated Children Aged ≥ 5 Years, in a Multisite Longitudinal CohortCynthia Porter, Zoe L Lyski, Jennifer L Uhrlaub, et al.
Journal of the Pediatric Infectious Diseases Society|December 10, 2024
Protection From COVID-19 Vaccination and Prior SARS-CoV-2 Infection Among Children Aged 6 Months-4 Years, United States, September 2022-April 2023Leora R Feldstein, Jasmine Ruffin, Ryan Wiegand, et al.
Pageof 12